Lev Pharmaceuticals, Inc. to Present at the Jefferies & Co. 2nd Annual Healthcare Conference

NEW YORK--(BUSINESS WIRE)--Lev Pharmaceuticals, Inc. ("Lev" or the "Company") (OTCBB:LEVP) announced today that Joshua Schein, Ph.D., chief executive officer of Lev will present at the Jefferies & Co. 2nd Annual Healthcare Conference, being held June 24-26 in New York City, NY. Dr. Schein will present a corporate progress report, including an update on the Company's lead product candidate, Cinryze™ [C1 inhibitor (human)]. The Lev presentation is scheduled to begin at 1:30 p.m. Eastern Standard Time on Thursday, June 26th.